Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin

Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin

Chromoblastomycosis (CBM) is a neglected human disease, caused by different species of pigmented dematiaceous fungi that cause granulomatous and suppurative dermatosis. This infection is difficult to treat and there are limited therapeutic options, including terbinafine, itraconazole, and tioconazol...

Detaylı Bibliyografya
Asıl Yazarlar:	Walter Belda, Luiz Felipe Domingues Passero, Caroline Heleno Chagas de Carvalho, Paula Celeste Rubiano Mojica, Pablo Andrade Vale
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	MDPI AG 2023-11-01
Seri Bilgileri:	Diseases
Konular:	chromoblastomycosis treatment acitretin imiquimod
Online Erişim:	https://www.mdpi.com/2079-9721/11/4/162

Benzer Materyaller

Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy
Yazar:: Jinjin Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Acitretin in dermatology
Yazar:: Rashmi Sarkar, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

New Immunological Markers in Chromoblastomycosis—The Importance of PD-1 and PD-L1 Molecules in Human Infection
Yazar:: Italo N. Cavallone, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Oral isotretinoin versus acitretin in the treatment of plantar warts in adults
Yazar:: Ahmad A.E. Nofal, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Acitretin-Induced Necrotizing Sweet’s Syndrome in a Patient Having Psoriasis
Yazar:: Karolina Nemeth, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Evaluation of acitretin side effects on Iraqi psoriatic patients
Yazar:: Ahmed H. Kadhim‎, ve diğerleri
Baskı/Yayın Bilgisi: (2010-12-01)

An unusually subtle presentation of chromoblastomycosis
Yazar:: William C. Lau, BA, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Successful treatment of chromoblastomycosis using cryosurgery in association with low-dose itraconazole
Yazar:: Talira Caserta Gon, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Electric Heating Pad as an Adjuvant Treatment of Extensive Chromoblastomycosis in Immunocompetent Patient: A Case Report
Yazar:: Hidayah RMN, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01)

Combined Abrocitinib and Acitretin Therapy for Darier’s Disease: A Case Report
Yazar:: Ye H, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Chromoblastomycosis: A case series and literature review
Yazar:: Manjunath M Shenoy, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Chromoblastomycosis presenting with sporotrichoid distribution and bony destruction: A rare presentation
Yazar:: Angoori Gnaneshwar Rao, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE
Yazar:: Flavio QUEIROZ-TELLES
Baskı/Yayın Bilgisi: (2015-09-01)

Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association
Yazar:: Vicente Sperb Antonello, ve diğerleri
Baskı/Yayın Bilgisi: (2010-12-01)

Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis
Yazar:: Vidal Mônica Scarpelli Martinelli, ve diğerleri
Baskı/Yayın Bilgisi: (2003-01-01)

Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers
Yazar:: Anne-Lise Bienvenu, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis Tratamento com posaconazol de casos de cromoblastomicose e micetoma maduromicótico resistentes a outros antifúngicos
Yazar:: Ricardo Negroni, ve diğerleri
Baskı/Yayın Bilgisi: (2005-12-01)

Chromoblastomycosis in French Guiana: Epidemiology and Practices, 1955–2023
Yazar:: Julie Valentin, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis
Yazar:: Claudio Guedes Salgado, ve diğerleri
Baskı/Yayın Bilgisi: (2004-02-01)

Fonsecaea pedrosoi cerebral phaeohyphomycosis ("chromoblastomycosis"): first human culture-proven case reported in Brazil
Yazar:: José Paulo S. Nóbrega, ve diğerleri
Baskı/Yayın Bilgisi: (2003-08-01)

Development of PCR-Multiplex Assays for Identification of the Herpotrichiellaceae Family and Agents Causing Chromoblastomycosis
Yazar:: Gabriel S. M. Sousa, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Molecular Diagnosis of Two Major Implantation Mycoses: Chromoblastomycosis and Sporotrichosis
Yazar:: Danièle Maubon, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

The pattern of immune cell infiltration in chromoblastomycosis: involvement of macrophage inflammatory protein-1 alpha/CCL3 and fungi persistence Padrão de infiltração de células do sistema imune na cromomicose: envolvimento de MIP-1 alfa da persistência fúngica
Yazar:: Vanuza Cristina Sá, ve diğerleri
Baskı/Yayın Bilgisi: (2007-02-01)

Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis
Yazar:: Leandro C. D. Breda, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Frizzled-related proteins 4 (SFRP4) rs1802073G allele predicts the elevated serum lipid levels during acitretin treatment in psoriatic patients from Hunan, China
Yazar:: Xingchen Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Chromoblastomycosis Due to a Never-before-Seen Dematiaceous Fungus in a Kidney Transplant Patient
Yazar:: Hélène Guegan, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Non-invasive Imaging Techniques for the Diagnosis of Chromoblastomycosis
Yazar:: Giulio Cortonesi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Triple therapy approach for treating chromoblastomycosis in a Lebanese patient
Yazar:: Joe Khodeir, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Chromoblastomycosis in an Endemic Area of Brazil: A Clinical-Epidemiological Analysis and a Worldwide Haplotype Network
Yazar:: Daniel Wagner C. L. Santos, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Chromoblastomycosis caused by Alternaria infectoria, concurrent with myiasis, in a recipient of a kidney transplant: a compelling case report
Yazar:: Hamidreza Mahmoudi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide–Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis
Yazar:: Hassan Raza, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

G alleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates
Yazar:: Dongmei Shi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Cladophialophora carrionii: a rare agent of chromoblastomycosis in Rio de Janeiro State, Brazil Cladophialophora carrionii: agente raro de cromoblastomicose no estado do Rio de Janeiro, Brasil
Yazar:: Marcelle de F. Mouchalouat, ve diğerleri
Baskı/Yayın Bilgisi: (2008-12-01)

Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole
Yazar:: Rowena Alves Coelho, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
Yazar:: Luiz Felipe Domingues Passero, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine
Yazar:: Xu-Cheng Shen, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

Secretion of five extracellular enzymes by strains of chromoblastomycosis agents Secreção de cinco enzimas extracelulares por amostras de agentes da cromoblastomicose
Yazar:: Thais Furtado de Souza, ve diğerleri
Baskı/Yayın Bilgisi: (2008-10-01)

Chromoblastomycosis Caused by <i>Phialophora</i>—Proven Cases from Mexico
Yazar:: Sarah A. Ahmed, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora In Vitro
Yazar:: Xinyao Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Partial chemical characterization of antigenic preparations of chromoblastomycosis agents Caracterização química parcial de preparações antigênicas de agentes da cromoblastomicose
Yazar:: Tania Fraga BARROS, ve diğerleri
Baskı/Yayın Bilgisi: (1999-11-01)